Drs Ursula A. Matulonis and Gini F. Fleming discuss the state of endometrial cancer, the role of immunotherapy, and priorities for research in this field.

A retrospective study showed that either folate receptor alpha or B7-H4 was expressed in more than 80% of endometrial cancers ...

Dual checkpoint inhibitors led to longer overall survival in patients with high-risk endometrial cancer who displayed ...

Zentalis Pharmaceuticals, Inc.’s ZNTL share price has dipped by 8.97%, which has investors questioning if this is right time ...

Histopathology and cytology of the fluid collection revealed high-grade serous endometrial carcinoma. Recurrence in the incision has previously been described in the literature, however not as a fluid ...

Oncology nurses can enhance endometrial cancer recovery by fostering strong social support networks and improving ...

The following is a summary of “Disparities in clinical drug trial participation in endometrial cancer: a real-world analysis, ...

Neoadjuvant nivolumab has demonstrated efficacy in patients with mismatch repair-deficient (dMMR), surgically resectable endometrial cancer, according to findings presented at the SGO 2025 Annual ...

Uterine cancer, which often begins in the lining—or endometrium—of the uterus, is the most common cancer of the female reproductive system and usually occurs in people over age 55. Learn more ...

While the presence of endometrial cells makes it an ideal tool for studying endometriosis, menstrual blood is also being used ...